A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics

Claire L. Mitchell, J. P. B. O’Connor, C. Roberts, Y. Watson, A. Jackson, S. Cheung, J. Evans, J. Spicer, A. Harris, C. Kelly, S. Rudman, M. Middleton, A. Fielding, J. Tessier, H. Young, G. J. M. Parker, G. C. Jayson

Open source

DOI: 10.1007/s00280-010-1534-3
Published: 2010-12-01
Container: Cancer Chemotherapy and Pharmacology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00280-010-1534-3,
  title = {A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics},
  author = {Claire L. Mitchell and J. P. B. O’Connor and C. Roberts and Y. Watson and A. Jackson and S. Cheung and J. Evans and J. Spicer and A. Harris and C. Kelly and S. Rudman and M. Middleton and A. Fielding and J. Tessier and H. Young and G. J. M. Parker and G. C. Jayson},
  year = {2010},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s00280-010-1534-3},
  url = {https://doi.org/10.1007/s00280-010-1534-3}
}

RIS

TY  - JOUR
TI  - A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics
AU  - Claire L. Mitchell
AU  - J. P. B. O’Connor
AU  - C. Roberts
AU  - Y. Watson
AU  - A. Jackson
AU  - S. Cheung
AU  - J. Evans
AU  - J. Spicer
AU  - A. Harris
AU  - C. Kelly
AU  - S. Rudman
AU  - M. Middleton
AU  - A. Fielding
AU  - J. Tessier
AU  - H. Young
AU  - G. J. M. Parker
AU  - G. C. Jayson
PY  - 2010
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s00280-010-1534-3
UR  - https://doi.org/10.1007/s00280-010-1534-3
ER  -

APA

Mitchell, C. L., O’Connor, J. P. B., Roberts, C., Watson, Y., Jackson, A., Cheung, S., Evans, J., Spicer, J., Harris, A., Kelly, C., Rudman, S., Middleton, M., Fielding, A., Tessier, J., Young, H., Parker, G. J. M., & Jayson, G. C. (2010). A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-010-1534-3

Source records

crossref · retrieved 2026-11-09T07:36:35.820Z